Wave Life Sciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $602.1M | $302.1M | $200.4M | $88.5M | $150.6M | $184.5M | $147.2M | $174.8M |
| Accounts Receivable | $1.3M | $1.4M | $21.1M | — | — | $30.0M | $20.0M | $10.0M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $614.8M | $320.4M | $235.4M | $98.5M | $162.6M | $230.0M | $185.5M | $202.3M |
| Property, Plant & Equipment | $7.4M | $10.1M | $13.1M | $17.3M | $22.3M | $29.2M | $36.4M | $39.9M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $638.5M | $352.2M | $274.9M | $146.4M | $207.0M | $279.2M | $284.3M | $295.9M |
| Liabilities | ||||||||
| Accounts Payable | $15.7M | $16.3M | $12.8M | $16.9M | $7.3M | $13.8M | $9.1M | $13.1M |
| Total Current Liabilities | $95.1M | $111.0M | $186.4M | $71.5M | $64.2M | $121.0M | $118.2M | $130.0M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $112.3M | $134.8M | $227.4M | $183.6M | $166.6M | $188.6M | $212.6M | $214.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967.3M | $-805.5M | $-683.3M | $-533.4M | $-339.7M |
| Total Stockholders' Equity | $518.4M | $209.5M | $39.6M | $-45.1M | $32.5M | $82.8M | $63.7M | $73.3M |